Biotech · Private company
Taisho Pharmaceutical R&D Inc.
Track this companyFree. Adds Taisho Pharmaceutical R&D Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- TS-121 10 mgPhase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- TS-121 50 mgPhase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- TS-142Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TS-161Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy ParticipantsPHASE1 · COMPLETED · started Sep 14, 2020ClinicalTrials.gov NCT04464239 · fetched Nov 12, 2026
- First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy ParticipantsPHASE1 · COMPLETED · started Jun 3, 2019ClinicalTrials.gov NCT03919409 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive DisorderPHASE2 · TERMINATED · started Jul 3, 2017ClinicalTrials.gov NCT03093025 · fetched Nov 12, 2026